Skip to main content

Soft Tissue Sarcoma Stages

After someone is diagnosed with a soft tissue sarcoma , doctors will try to figure out if it has spread, and if so, how far. This process is called staging. The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics.

The stages of soft tissue sarcomas range from stages I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more. And within a stage, an earlier letter means a lower stage. Although each person’s cancer experience is unique, cancers with similar stages tend to have a similar outlook and are often treated in much the same way.

How is the stage determined?

The staging system most often used for soft tissue sarcomas is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 4 key pieces of information:

  • The extent of the tumor (T): How large is the cancer?
  • The spread to nearby lymph nodes (N): Has the cancer spread to nearby lymph nodes?
  • The spread (metastasis) to distant sites (M): Has the cancer spread to distant organs such as the lungs?
  • The grade (G) of the cancer: How much do the sarcoma cells look like normal cells?

Grade

The grade is partly used to determine the stage of a sarcoma. The staging system divides sarcomas into 3 grades (1 to 3). The grade of a sarcoma helps predict how rapidly it will grow and spread. It's useful in predicting a patient's outlook and helps determine treatment options.

The grade of a sarcoma is determined using a system known as the French or FNCLCC system, and is based on 3 factors:

  • Differentiation: Cancer cells are given a score of 1 to 3, with 1 being assigned when they look a lot like normal cells and 3 being used when the cancer cells look very abnormal. Certain types of sarcoma are given a higher score automatically.
  • Mitotic count: How many cancer cells are seen dividing under the microscope; given a score from 1 to 3 (a lower score means fewer cells were seen dividing)
  • Tumor necrosis: How much of the tumor is made up of dying tissue; given a score from 0 to 2 (a lower score means there was less dying tissue present).

Each factor is given a score, and the scores are added to determine the grade of the tumor. Sarcomas that have cells that look more normal and have fewer cells dividing are generally placed in a low-grade category. Low-grade tumors tend to be slow growing, slower to spread, and often have a better outlook (prognosis) than higher-grade tumors. Certain types of sarcoma are automatically given higher differentiation scores. This affects the overall score so much that they are never considered low grade. Examples of these include synovial sarcomas and embryonal sarcomas. Here's what the grade numbers mean:

GX: The grade cannot be assessed (because of incomplete information).

Grade 1 (G1): Total score of 2 or 3

Grade 2 (G2): Total score of 4 or 5

Grade 3 (G3): Total score of 6, 7 or 8

Defining TNM

There are different staging systems for soft tissue sarcomas depending on where the cancer is in the body.

  • Head and neck
  • Trunk and extremities (arms and legs)
  • Abdomen and thoracic (chest) visceral organs
  • Retroperitoneum

Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced. Once a person’s T, N, and M categories have been determined, this information is combined in a process called stage grouping to assign an overall stage. Of the 4 main locations, only 2 (Trunk and Extremities and Retroperitoneum) have stage groupings. For more information see Cancer Staging.

The staging system in the table below uses the pathologic stage (also called the surgical stage). It is determined by examining tissue removed during an operation. Sometimes, if surgery is not possible right away or at all, the cancer will be given a clinical stage instead. This is based on the results of a physical exam, biopsy, and imaging tests. The clinical stage will be used to help plan treatment. Sometimes, though, the cancer has spread further than the clinical stage estimates, and may not predict the patient’s outlook as accurately as a pathologic stage.

The system described below is the most recent AJCC system, effective January 2018. Cancer staging can be complex, so ask your doctor to explain it to you in a way you understand. 

Trunk and Extremities Sarcoma Stages

AJCC stage

Stage grouping

Trunk and Extremities Sarcoma Stage description*

IA

T1

N0

M0

G1 or GX

The cancer is 5 cm (2 inches) or smaller (T1).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 1 (G1) or the grade cannot be assessed (GX).

IB

T2, T3, T4

N0

M0

G1 or GX

 

The cancer is:

  • Larger than 5 cm but not more than 10 cm (T2) OR
  • Larger than 10cm but not more than 15 cm (T3) OR
  • Larger than 15 cm (T4).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 1 (G1) or the grade cannot be assessed (GX).

 

II

T1

N0

M0

G2 or G3

The cancer is 5 cm (2 inches) or smaller (T1).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).

IIIA

 

T2

N0

M0

G2 or G3

The cancer is larger than 5 cm (2 inches) but not more than 10 cm (T2).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).

IIIB

T3 or T4

N0

M0

G2 or G3

The cancer is:

  • Larger than 10 cm but not more than 15 cm (T3) OR
  • Larger than 15 cm (T4).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).

IV

Any T

N1

M0

Any G

The cancer is any size (Any T) AND it has spread to nearby lymph nodes (N1).

It has not spread to distant sites (M0). It can be any grade.

OR

Any T

Any N

M1

Any G

The cancer is any size (Any T) AND it has spread to nearby lymph nodes (N1).

It has spread to distant sites such as the lungs (M1). It can be any grade.

 

*The following categories are not listed in the table above:

  • TX: Main tumor cannot be assessed due to lack of information.
  • T0: No evidence of a primary tumor.
  • NX: Regional lymph nodes cannot be assessed due to lack of information. 

Retroperitoneum Sarcoma Stages

AJCC stage

Stage grouping

Retroperitoneum Sarcoma Stage description*

IA

T1

N0

M0

G1 or GX

The cancer is 5 cm (2 inches) or smaller (T1).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 1 (G1) or the grade cannot be assessed (GX).

IB

T2, T3, T4

N0

M0

G1 or GX

The cancer is:

  • Larger than 5 cm but not more than 10 cm OR
  • Larger than 10 cm but not more than 15 cm (T3) OR
  • Larger than 15 cm (T4).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 1 (G1) or the grade cannot be assessed (GX).

 

II

T1

N0

M0

G2 or G3

The cancer is 5 cm (2 inches) or smaller (T1).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).

IIIA

 

T2

N0

M0

G2 or G3

The cancer is larger than 5 cm (2 inches) but not more than 10 cm (T2).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).

IIIB

T3 or T4

N0

M0

G2 or G3

The cancer is:

  • Larger than 10 cm but not more than 15 cm (T3) OR
  • Larger than 15 cm (T4).

It has not spread to nearby lymph nodes (N0) or to distant sites (M0). The cancer is grade 2 (G2) or grade 3 (G3).

OR

Any T

N1

M0

Any G

The cancer is any size (Any T) AND it has spread to nearby lymph nodes (N1).

It has not spread to distant sites (M0). It can be any grade.

IV

Any T

Any N

M1

Any G

The cancer is any size (Any T) AND it has spread to nearby lymph nodes (N1).

It has spread to distant sites such as the lungs (M1). It can be any grade.

 

*The following categories are not listed in the table above:

  • TX: Main tumor cannot be assessed due to lack of information.
  • T0: No evidence of a primary tumor.
  • NX: Regional lymph nodes cannot be assessed due to lack of information. 

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

American Joint Committee on Cancer. Soft Tissue Sarcoma of the Trunk and Extremities. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:507.

American Joint Committee on Cancer. Soft Tissue Sarcoma of the Retroperitoneum. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:531.

Last Revised: April 6, 2018

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.